Advertisement

Supply Chain



Facing ongoing pressure to reduce costs, hospitals and health systems are looking more closely at their supply chains as a source of significant, additional savings.

The FDA approved Novartis' cell therapy Kymriah to treat an additional type of blood cancer, the drugmaker announced May 1.

Major health systems today are quickly becoming sprawling networks of facilities due to growing rates of mergers and acquisitions throughout the healthcare industry. While many health systems scale up to remain competitive, such organizational growth presents logistical challenges, especially when…

Advertisement

Most Read

Advertisement
Advertisement